Johnson & Johnson - 64 Year Stock Price History | JNJ
Historical daily share price chart and data for Johnson & Johnson since 1962 adjusted for splits and dividends. The latest closing stock price for Johnson & Johnson as of February 10, 2026 is 238.35.
- The all-time high Johnson & Johnson stock closing price was 239.99 on February 06, 2026.
- The Johnson & Johnson 52-week high stock price is 240.94, which is 1.1% above the current share price.
- The Johnson & Johnson 52-week low stock price is 141.50, which is 40.6% below the current share price.
- The average Johnson & Johnson stock price for the last 52 weeks is 178.07.
| Johnson & Johnson Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2026 | 221.1244 | 207.3500 | 239.9900 | 204.3100 | 238.3500 | 15.17% |
| 2025 | 167.8268 | 139.7450 | 214.1700 | 137.8430 | 206.9500 | 47.48% |
| 2024 | 148.4928 | 150.4580 | 161.1190 | 136.8920 | 140.3270 | -4.81% |
| 2023 | 148.4135 | 162.6590 | 164.5390 | 135.8550 | 147.4200 | -8.58% |
| 2022 | 155.4149 | 152.5790 | 166.5120 | 141.5640 | 161.2530 | 5.98% |
| 2021 | 145.3165 | 135.7800 | 157.6570 | 133.6320 | 152.1610 | 11.44% |
| 2020 | 124.7676 | 123.2920 | 136.5440 | 94.4721 | 136.5440 | 10.82% |
| 2019 | 112.3188 | 104.9450 | 123.6890 | 103.2770 | 123.2080 | 16.22% |
| 2018 | 107.7790 | 111.3550 | 121.4480 | 96.8194 | 106.0130 | -5.13% |
| 2017 | 102.4706 | 90.3015 | 114.2820 | 87.1210 | 111.7470 | 24.43% |
| 2016 | 87.3699 | 76.1749 | 96.4397 | 72.5891 | 89.8104 | 15.33% |
| 2015 | 74.4960 | 76.9569 | 79.7911 | 68.2800 | 77.8731 | 1.14% |
| 2014 | 73.2463 | 65.2162 | 79.9021 | 62.0568 | 76.9937 | 17.34% |
| 2013 | 60.5594 | 49.2556 | 68.5118 | 49.1861 | 65.6174 | 34.62% |
| 2012 | 45.6954 | 44.1725 | 49.9818 | 42.1962 | 48.7411 | 10.85% |
| 2011 | 41.8276 | 40.6417 | 44.7231 | 37.6408 | 43.9714 | 9.89% |
| 2010 | 39.4781 | 40.4191 | 41.5785 | 36.2329 | 40.0142 | -0.59% |
| 2009 | 35.5399 | 36.6697 | 40.5941 | 28.4086 | 40.2504 | 11.27% |
| 2008 | 38.6521 | 38.7348 | 43.3052 | 33.4532 | 36.1740 | -7.72% |
| 2007 | 37.1082 | 38.0503 | 40.1981 | 34.5830 | 39.1990 | 3.61% |
| 2006 | 35.2341 | 34.5051 | 39.3752 | 31.8009 | 37.8326 | 12.43% |
| 2005 | 35.8506 | 34.5332 | 38.2668 | 33.6149 | 33.6485 | -3.36% |
| 2004 | 30.4003 | 27.8165 | 35.0054 | 26.7710 | 34.8187 | 25.17% |
| 2003 | 28.0588 | 29.2628 | 31.1570 | 26.1138 | 27.8165 | -2.08% |
| 2002 | 30.2693 | 30.6270 | 34.2759 | 21.9777 | 28.4061 | -7.88% |
| 2001 | 26.9287 | 26.2600 | 31.8114 | 21.5047 | 30.8357 | 14.00% |
| 2000 | 22.8309 | 23.4055 | 27.0484 | 17.4541 | 27.0484 | 14.25% |
| 1999 | 23.7457 | 20.7512 | 26.9441 | 19.3238 | 23.6753 | 12.48% |
| 1998 | 18.7147 | 16.1184 | 22.3353 | 15.8551 | 21.0492 | 28.98% |
| 1997 | 14.6727 | 12.1522 | 16.5829 | 12.1522 | 16.3196 | 34.29% |
| 1996 | 11.7769 | 10.1390 | 13.1293 | 10.0789 | 12.1522 | 18.10% |
| 1995 | 8.2171 | 6.4368 | 11.0115 | 6.3482 | 10.2895 | 59.13% |
| 1994 | 5.3983 | 5.2142 | 6.5549 | 4.2607 | 6.4663 | 25.05% |
| 1993 | 4.7807 | 5.5678 | 5.5678 | 4.0803 | 5.1710 | -8.97% |
| 1992 | 5.5016 | 6.2005 | 6.4283 | 4.8055 | 5.6803 | -10.19% |
| 1991 | 4.9130 | 3.8015 | 6.3800 | 3.5639 | 6.3247 | 62.31% |
| 1990 | 3.3796 | 3.1841 | 3.9445 | 2.7653 | 3.8966 | 23.40% |
| 1989 | 2.6584 | 2.2182 | 3.1576 | 2.2182 | 3.1576 | 39.84% |
| 1988 | 2.1461 | 2.0691 | 2.3367 | 1.8421 | 2.2580 | 13.86% |
| 1987 | 2.2813 | 1.7823 | 2.7701 | 1.7077 | 1.9831 | 14.23% |
| 1986 | 1.6844 | 1.3705 | 1.9537 | 1.2615 | 1.7361 | 24.87% |
| 1985 | 1.1757 | 0.9395 | 1.4464 | 0.9263 | 1.3903 | 45.93% |
| 1984 | 0.9033 | 1.0757 | 1.1151 | 0.7442 | 0.9527 | -11.43% |
| 1983 | 1.2008 | 1.3008 | 1.3434 | 1.0329 | 1.0757 | -17.51% |
| 1982 | 1.0726 | 0.9610 | 1.3401 | 0.8531 | 1.3040 | 33.87% |
| 1981 | 0.8956 | 0.8723 | 1.0094 | 0.7475 | 0.9741 | 11.80% |
| 1980 | 0.6930 | 0.6700 | 0.8734 | 0.5806 | 0.8713 | 25.95% |
| 1979 | 0.6293 | 0.6478 | 0.6984 | 0.5652 | 0.6918 | 7.52% |
| 1978 | 0.6694 | 0.6540 | 0.7742 | 0.5745 | 0.6434 | -3.87% |
| 1977 | 0.6134 | 0.6810 | 0.6810 | 0.5460 | 0.6693 | -1.56% |
| 1976 | 0.7525 | 0.7854 | 0.8377 | 0.6276 | 0.6799 | -13.07% |
| 1975 | 0.7752 | 0.7232 | 0.8627 | 0.6426 | 0.7821 | 11.00% |
| 1974 | 0.8587 | 0.9735 | 1.0356 | 0.6545 | 0.7046 | -28.26% |
| 1973 | 1.0355 | 1.1193 | 1.1367 | 0.9103 | 0.9822 | -13.59% |
| 1972 | 1.0272 | 0.8514 | 1.1509 | 0.8264 | 1.1367 | 32.50% |
| 1971 | 0.7413 | 0.4986 | 0.8612 | 0.4986 | 0.8579 | 72.82% |
| 1970 | 0.4480 | 0.5094 | 0.5160 | 0.3255 | 0.4964 | -5.00% |
| 1969 | 0.3710 | 0.3070 | 0.5225 | 0.2939 | 0.5225 | 69.04% |
| 1968 | 0.2568 | 0.2612 | 0.3091 | 0.2170 | 0.3091 | 16.07% |
| 1967 | 0.2223 | 0.1635 | 0.2779 | 0.1606 | 0.2663 | 61.00% |
| 1966 | 0.1681 | 0.1693 | 0.1935 | 0.1353 | 0.1654 | -0.78% |
| 1965 | 0.1343 | 0.1076 | 0.1688 | 0.1076 | 0.1667 | 54.21% |
| 1964 | 0.1016 | 0.1010 | 0.1152 | 0.0929 | 0.1081 | 9.52% |
| 1963 | 0.0869 | 0.0723 | 0.1148 | 0.0719 | 0.0987 | 39.21% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Large Cap Pharmaceutical | $555.945B | $94.193B |
| Johnson & Johnson's biggest strength is its diversified business model. It operates through pharmaceuticals, medical devices and consumer products divisions. Its diversification helps it to withstand economic cycles more effectively. J&J has one of the largest research and development (R&D) budget among pharma companies. J&J's worldwide business is divided into three segments: Pharmaceutical, Medical Devices and Consumer. The company has several drugs covering a broad range of areas such as neuroscience, cardiovascular & metabolism, immunology, oncology, pulmonary hypertension and infectious diseases and vaccines. The Medical Devices Segment offers products in the orthopedics, surgery, interventional solutions and vision markets. The Consumer Segment segment includes a broad range of products covering the areas of baby care, beauty/skin health, oral care, wound care and womens' health care, as well as over-the-counter (OTC) pharmaceutical products. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eli Lilly (LLY) | United States | $987.104B | 47.48 |
| AbbVie (ABBV) | United States | $398.793B | 23.88 |
| Roche Holding AG (RHHBY) | Switzerland | $363.885B | 0.00 |
| Novartis AG (NVS) | Switzerland | $319.060B | 16.91 |
| Merck (MRK) | United States | $281.387B | 13.11 |
| Novo Nordisk (NVO) | Denmark | $263.122B | 15.43 |
| Pfizer (PFE) | United States | $151.581B | 8.33 |
| Sanofi (SNY) | France | $115.292B | 10.67 |
| Innoviva (INVA) | United States | $1.569B | 7.86 |